We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Shengtai Pharmaceutical Inc (GM) | USOTC:SGTI | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.000001 | 0.000001 | 0.00 | 01:00:00 |
As filed with the Securities and Exchange Commission on July 30, 2013
1933 Act Registration No. 33-72424
1940 Act Registration No. 811-8194
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-1A
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 |
x |
Pre-Effective Amendment No. |
|
Post-Effective Amendment No. 117 |
x |
|
|
and/or |
|
|
|
REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940 |
x |
Amendment No. 118 |
x |
(Check appropriate box or boxes.)
FINANCIAL INVESTORS TRUST
(Exact name of Registrant as Specified in Charter)
1290 Broadway, Suite 1100
Denver, CO 80203
(Address of principal executive offices) (Zip Code)
Registrant ’ s Telephone Number, including Area Code: (303) 623-2577
David T. Buhler, Esq., Secretary
Financial Investors Trust
1290 Broadway, Suite 1100
Denver, CO 80203
(Name and Address of Agent of Service)
Copy to:
Peter H. Schwartz, Esq.
Davis Graham & Stubbs LLP
1550 17 th Street, Suite 500
Denver, CO 80202
Approximate Date of Proposed Public Offering: As soon as practicable after the effective date of this Amendment
It is proposed that this filing will become effective (check appropriate box):
|
|
immediately upon filing pursuant to paragraph (b) |
x |
|
on August 29, 2013, pursuant to paragraph (b) |
|
|
60 days after filing pursuant to paragraph (a) (1) |
|
|
on, (date), pursuant to paragraph (a) (1) |
|
|
75 days after filing pursuant to paragraph (a) (2) |
|
|
on (date), pursuant to paragraph (a) (2) |
If appropriate, check the following box:
x |
|
This post-effective amendment designates a new effective date for a previously filed post-effective amendment. |
1
The sole purpose of this filing is to delay the effectiveness of the Trust ’ s Post-Effective Amendment No. 114 to its Registration Statement until August 29, 2013. Post-Effective Amendment No. 114 to the Trust ’ s Registration Statement relates to the Real Asset Income Fund. Parts A, B and C of Registrant ’ s Post-Effective Amendment No. 114 under the Securities Act of 1933 and Amendment No. 115 under the Investment Company Act of 1940, filed on May 15, 2013, are incorporated by reference herein.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, has duly caused this Post-Effective Amendment No. 117 of its Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Denver, and State of Colorado, on July 30, 2013.
FINANCIAL INVESTORS TRUST
(Registrant)
By : |
/ s/ Edmund J. Burke |
|
Edmund J. Burke |
|
President |
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.
Signature |
|
Title |
|
Date |
|
|
|
|
|
/s/ Edmund J. Burke |
|
President, Trustee and Chairman |
|
July 30, 2013 |
Edmund J. Burke |
|
|
|
|
|
|
|
|
|
/s/ John R. Moran, Jr. |
|
Trustee |
|
July 30, 2013 |
John R. Moran, Jr.* |
|
|
|
|
|
|
|
|
|
/s/ Jeremy W. Deems |
|
Trustee |
|
July 30, 2013 |
Jeremy W. Deems* |
|
|
|
|
|
|
|
|
|
/s/ Mary K. Anstine |
|
Trustee |
|
July 30, 2013 |
Mary K. Anstine* |
|
|
|
|
|
|
|
|
|
/s/ Jerry G. Rutledge |
|
Trustee |
|
July 30, 2013 |
Jerry G. Rutledge* |
|
|
|
|
|
|
|
|
|
/s/ Michael “ Ross ” Shell |
|
Trustee |
|
July 30, 2013 |
Michael “ Ross ” Shell* |
|
|
|
|
|
|
|
|
|
/s/ Kimberly R. Storms |
|
Treasurer |
|
July 30, 2013 |
Kimberly R. Storms |
|
|
|
|
*
Signature affixed by David T. Buhler pursuant to a power of attorney dated September 11, 2012.
2
1 Year Shengtai Pharmaceutical (GM) Chart |
1 Month Shengtai Pharmaceutical (GM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions